Bio Green Valuation
| BGMS Stock | 1.04 0.03 2.80% |
Today, the firm appears to be overvalued. Bio Green Med shows a prevailing Real Value of USD1.0 per share. The current price of the firm is USD1.04. Our model approximates the value of Bio Green Med from analyzing the firm fundamentals such as Shares Outstanding of 2.94 M, operating margin of (12.25) %, and Return On Equity of -1.78 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bio Green's valuation include:
Price Book 0.6772 | Enterprise Value | Enterprise Value Ebitda 0.0179 | Price Sales 35.5697 | Enterprise Value Revenue 12.001 |
Overvalued
Today
Please note that Bio Green's price fluctuation is abnormally volatile at this time. Calculation of the real value of Bio Green Med is based on 3 months time horizon. Increasing Bio Green's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bio stock is determined by what a typical buyer is willing to pay for full or partial control of Bio Green Med. Since Bio Green is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bio Stock. However, Bio Green's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.04 | Real 1.0 | Hype 1.05 | Naive 1.27 |
The intrinsic value of Bio Green's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bio Green's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bio Green Med helps investors to forecast how Bio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio Green more accurately as focusing exclusively on Bio Green's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bio Green's intrinsic value based on its ongoing forecasts of Bio Green's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bio Green's closest peers.
Bio Green Cash |
|
About Bio Green Valuation
The stock valuation mechanism determines Bio Green's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bio Green Med based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio Green. We calculate exposure to Bio Green's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bio Green's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 49.5 K | 51.9 K | |
| Pretax Profit Margin | (320.77) | (304.73) | |
| Operating Profit Margin | (321.04) | (304.99) | |
| Net Loss | (299.86) | (284.86) | |
| Gross Profit Margin | (32.02) | (30.42) |
Bio Green Current Valuation Indicators
Bio Green's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Bio Green's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bio Green, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bio Green's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bio Green's worth.Additional Tools for Bio Stock Analysis
When running Bio Green's price analysis, check to measure Bio Green's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Green is operating at the current time. Most of Bio Green's value examination focuses on studying past and present price action to predict the probability of Bio Green's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Green's price. Additionally, you may evaluate how the addition of Bio Green to your portfolios can decrease your overall portfolio volatility.